MedPath

The effect of temperature of intravenous administration on occurrence of phlebitis and dwell time of intravenous catheters.

Phase 2
Conditions
Phlebitis.
Phlebitis and thrombophlebitis of other sites
Registration Number
IRCT2017011531959N1
Lead Sponsor
Vice Chancellor for Research of Gonabad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
106
Inclusion Criteria

Inclusion Criteria: Having informed consent for research; Age 18-65 years; having full consciousness; not having underlying diseases such as leukemia; immune deficiency and dermatitis; healthy upper limb, do not receive Immunosuppressant’s drug and chemotherapy; having a minimum of 72 hours intravenous catheter; don’t receive drugs that stimulate the vein wall and solution Hyperosmolar; no history of intravenous drug addiction.

Exclusion Criteria

Disrupting or failure to completing the study because of transition to other unit or death; unwillingness to continue the study; need to receive stimulating and Hyperosmolar solutions and drugs during the study; receive intravenous fluids and medications less than 72 hours; sensitivity to adhesives.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Phlebitis. Timepoint: 24, 48 and 72 hours after intervention. Method of measurement: Phlebitis Scale from the Infusion Nurses society.
Secondary Outcome Measures
NameTimeMethod
Dwell time of intravenous catheter. Timepoint: Time between insertion and discontinue of catheter. Method of measurement: Per hour.
© Copyright 2025. All Rights Reserved by MedPath